Update on the pathophysiology and management of idiopathic intracranial hypertension

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 5, 2012, Pages 488-494

  Biousse, Valérie ^a   Bruce, Beau B ^a   Newman, Nancy J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; OCTREOTIDE; PLACEBO; STEROID; TOPIRAMATE;

CEREBROSPINAL FLUID SHUNTING; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION; LETHARGY; LUMBAR PUNCTURE; OBESITY; PARESTHESIA; PATHOGENESIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SIDE EFFECT; STENT; TASTE DISORDER; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84859728901     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-302029     Document Type: Review

References (67)

1. Ko MW, Liu GT. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr 2010;74:381-9.
2. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-5. (Pubitemid 35387052)
3. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol 2004;24:138-45. (Pubitemid 38720671)
4. Wall M. Idiopathic intracranial hypertension. Neurol Clin 2010;28:593-617.
5. Digre KB. Idiopathic intracranial hypertension. BMJ 2010;341:c2836.
6. Kapoor KG. More than meets the eye? Redefining idiopathic intracranial hypertension. Int J Neurosci 2010;120:471-82.
7. Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46:198-202. (Pubitemid 26156129)
8. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003;60:1418-24. (Pubitemid 36554799)
9. Degnan AJ, Levy LM. Pseudotumor cerebri: brief review of clinical syndrome and imaging findings. AJNR Am J Neuroradiol 2011;32:1986-93.
10. Rohr AC, Riedel C, Fruehauf MC, et al. MR imaging findings in patients with secondary intracranial hypertension. AJNR Am J Neuroradiol 2011;32:1021-9.
11. Connor SE, Siddiqui MA, Stewart VR, et al. The relationship of transverse sinus stenosis to bony groove dimensions provides an insight into the aetiology of idiopathic intracranial hypertension. Neuroradiology 2008;50:999-1004.
12. Shofty B, Ben-Sira L, Constantini S, et al. Optic nerve sheath diameter on MR imaging: Establishment of norms and comparison of pediatric patients with idiopathic intracranial hypertension with healthy controls. AJNR Am J Neuroradiol. 2012;33:366-9.
13. Friesner D, Rosenman R, Lobb BM, et al. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 2011;12:-372-80.
14. Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007;143:635-41.
15. Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 2011;76:1564-7.
16. Szewka AJ, Bruce BB, Newman NJ, et al. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol. Published Online First: 3 January 2012.
17. Kesler A, Kliper E, Shenkerman G, et al. Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 2010;117:169-74.
18. Ooi LY, Walker BR, Bodkin PA, et al. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg. 2008;22:187-94. (Pubitemid 351414890)
19. Bruce BB, Kedar S, Van Stavern GP, et al. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010;74:1827-32.
20. Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology 2009;72:304-9.
21. Kim TW, Choung HK, Khwarg SI, et al. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol 2008;15:876-9.
22. Bruce BB, Preechawat P, Newman NJ, et al. Racial differences in idiopathic intracranial hypertension. Neurology 2008;70:861-7. (Pubitemid 351367507)
23. Mrejen S, Vignal C, Bruce BB, et al. Idiopathic intracranial hypertension: a comparison between French and North-American white patients. Rev Neurol (Paris) 2009;165:542-8.
24. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 2005;6:29-37.
25. Kesler A, Goldhammer Y, Hadayer A, et al. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol Scand 2004;110:408-11. (Pubitemid 39536524)
26. Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocyclin treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998;126:116-21. (Pubitemid 28341226)
27. Wall M, Purvin V. Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology 2009;72:300-1.
28. Thurtell MJ, Bruce BB, Rye DB, et al. The Berlin questionnaire screens for obstructive sleep apnea in idiopathic intracranial hypertension. J Neuroophthalmol 2011;31:316-19.
29. Libien J, Blaner WS. Retinol and retinol-binding protein in cerebrospinal fluid: can vitamin A take the "idiopathic" out of idiopathic intracranial hypertension? J Neuroophthalmol 2007;27:253-7. (Pubitemid 350307642)
30. Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005;64:1893-6. (Pubitemid 40800703)
31. Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007;27:258-62. (Pubitemid 350307643)
32. Wozniak SE, Gee LL, Wachtel MS, et al. Adipose tissue: the new endocrine organ? Dig Dis Sci 2009;54:1847-56.
33. Glueck CJ, Aregawi D, Goldenberg N, et al. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med 2005;145:72-82. (Pubitemid 40298732)
34. Fraser JA, Bruce BB, Rucker J, et al. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci 2010;290:86-9.
35. Dhungana S, Waters P, Ismail A, et al. Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neurol 2010;257:1211-12. Corrected and republished in: J Neurol 2010;257:1229-30.
36. Kerty E, Heuser K, Indahl UG, et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol. Published Online First: 13 September 2011. doi:10.1111/j.1755-3768. 2011.02231.x
37. Brettschneider J, Hartmann N, Lehmensiek V, et al. Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved? Cephalalgia 2011;31:116-21.
38. Sinclair AJ, Viant MR, Ball AK, et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological disease - a diagnostic tool? NMR Biomed 2010;23:123-32.
39. Strydom MA, Briers N, Bosman MC, et al. The anatomical basis of venographic filling defects of the transverse sinus. Clin Anat 2010;23:153-9.
40. Bateman GA, Stevens SA, Stimpson J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg 2009;110:446-56.
41. Sander K, Poppert H, Etgen T, et al. Dynamics of intracranial venous flow patterns in patients with idiopathic intracranial hypertension. Eur Neurol 2011;66:334-8.
42. Rohr A, Bindeballe J, Riedel C, et al. The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: a longitudinal, volumetric magnetic resonance imaging study. Neuroradiology 2012;54:25-33.
43. Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 2011;31:374-80.
44. Stienen A, Weinzierl M, Ludolph A, et al. Obstruction of cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol 2008;15:1416-18.
45. Albuquerque FC, Dashti SR, Hu YC, et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg 2011;75:648-52.
46. Kesler A, Kliper E, Assayag EB, et al. Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis 2010;21:328-33.
47. Hannerz J, Antovic JP, Blombäck M, et al. Inflammatory and haemostatic markers in idiopathic intracranial hypertension. J Intern Med 2011;270:496-9.
48. Biousse V, Rucker JC, Vignal C, et al. Anemia and papilledema. Am J Ophthalmol 2003;135:437-46. (Pubitemid 36315952)
49. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999;53:1537-42. (Pubitemid 29491950)
50. De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 2005;25:342-4. (Pubitemid 40347913)
51. Wong R, Madill SA, Pandey P, et al. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007;7:15.
52. Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 2010;341:c2701.
53. Egan RJ, Meredith HE, Coulston JE, et al. The effects of laparoscopic adjustable gastric banding on idiopathic intracranial hypertension. Obes Surg 2011;21:161-6.
54. Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 2011;114:34-9.
55. Rubin RC, Henderson ES, Ommaya AK, et al. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 1966;25:430-6.
56. Ball AK, Howman A, Wheatley K, et al. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 2011;258:874-81.
57. Celebisoy N, Gokcay F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007;116:322-7. (Pubitemid 47537419)
58. Deftereos SN, Panagopoulos G, Georgonikou D, et al. Treatment of idiopathic intracranial hypertension: is there a place for octreotide? Cephalalgia 2011;31:1679-80.
59. Thambisetty M, Lavin PJ, Newman NJ, et al. Fulminant idiopathic intracranial hypertension. Neurology 2007;68:229-32. (Pubitemid 46105743)
60. Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 2011;31:1627-33.
61. Ulivieri S, Oliveri G, Georgantzinou M, et al. Long-term effectiveness of lumboperitoneal flow-regulated shunt system for idiopathic intracranial hypertension. J Neurosurg Sci 2009;53:107-11.
62. El-Saadany WF, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome. Neurosurg Rev 2012;35:239-44.
63. Kandasamy J, Hayhurst C, Clark S, et al. Electromagnetic stereotactic ventriculoperitoneal CSF shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg 2011;75:155-60.
64. Tarnaris A, Toma AK, Watkins LD, et al. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg 2011;113:477-9.
65. Abubaker K, Ali Z, Raza K, et al. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts - case series and literature review. Br J Neurosurg 2011;25:94-9.
66. Alsuhaibani AH, Carter KD, Nerad JA, et al. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology 2011;118:412-14.
67. Ahmed RM, Wilkinson M, Parker GD, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 2011;32:1408-14.